Takeda Pharmaceutical Company Overview
- Status
-
Public
- Employees
-
47,347
- Stock Symbol
-
4502
- Investments
-
57
- Share Price
-
$27.87
- (As of Monday Closing)
Takeda Pharmaceutical Company General Information
Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
- 1-1, Nihonbashi-Honcho 2-Chome
- Chuo-Ku
- Tokyo, 103-8668
- Japan
+81 00-0000-0000
Takeda Pharmaceutical Company Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $27.87 | $28.15 | $26.10 - $34.88 | $43.3B | 1.55B | 5.53M | $1.08 |
Takeda Pharmaceutical Company Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 71,840,075 | 76,014,887 | 96,707,668 | 90,260,680 |
| Revenue | 30,605,957 | 31,768,761 | 30,156,800 | 30,268,671 |
| EBITDA | 7,845,376 | 8,933,006 | 9,948,472 | 6,076,408 |
| Net Income | 1,681,933 | 2,047,822 | 3,545,896 | 406,879 |
| Total Assets | 102,974,770 | 107,974,090 | 117,048,645 | 118,633,583 |
| Total Debt | 33,693,686 | 35,604,125 | 42,019,175 | 47,128,342 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Takeda Pharmaceutical Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Takeda Pharmaceutical Company Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The co
Pharmaceuticals
Tokyo, Japan
47,347
As of 2022
00000000
000000
fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000 000000000
Tokyo, Japan
00000
As of 0000
00.000
00000000
00.000
000000
olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
000000000000000
Basel, Switzerland
000000
As of 0000
000000000000
Add Comparison
Takeda Pharmaceutical Company Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Otsuka Holdings | Corporation | Tokyo, Japan | 00000 | 00.000 | 00000000 | 00.000 |
| 00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
| 000000000000000 | Corporation | Brentford, United Kingdom | 00000 | 000000000 | ||
| 00000000 00000 | Corporation | Mumbai, India | 00 | 00.000 | 00000000000 | 00.000 |
| 00000000 000000 | Corporation | Tokyo, Japan | 00000 | 000000&0 |
Takeda Pharmaceutical Company Patents
Takeda Pharmaceutical Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220106357-A1 | Plasma fractionation utilizing spray-dried human plasma | Pending | 01-Oct-2020 | 000000000 | |
| JP-2021183587-A | Heterocyclic compounds | Pending | 22-May-2020 | 0000000000 | |
| JP-2021183586-A | Heterocyclic compounds | Pending | 22-May-2020 | 0000000000 | |
| JP-2021138648-A | Oral solid preparation | Pending | 04-Mar-2020 | 0000000000 | |
| US-20210315198-A1 | Compositions and methods of cryopreserving cells | Pending | 21-Jan-2020 | A01N1/0221 |
Takeda Pharmaceutical Company Executive Team (53)
Takeda Pharmaceutical Company Board Members (20)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000 00.0 | Takeda Pharmaceutical Company | Board Member & President | 000 0000 |
| 0000000000 00000 | Takeda Pharmaceutical Company | Chief Executive Officer & Board Member | 000 0000 |
| 00000 00000000 | Takeda Pharmaceutical Company | Chief Financial Officer, Finance & Board Member | 000 0000 |
| 00000 0000000 | Self | Board Member | 000 0000 |
| 00000 0000 | Takeda Pharmaceutical Company | Outside Director | 000 0000 |
Takeda Pharmaceutical Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Takeda Pharmaceutical Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Takeda Pharmaceutical Company Investments & Acquisitions (57)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 28-Jun-2022 | 000000000 | 00000 | Biotechnology | 0000 0000 |
| 00000000 0000 | 10-Jan-2022 | 0000000000 | Drug Discovery | 000000000 | |
| 000000000 000 | 27-Oct-2021 | 00000 0000 | 00000 | Biotechnology | |
| 0000000000 00 | 27-Oct-2021 | 0000000000 | Biotechnology | 000000000 | |
| Maverick Therapeutics | 01-Oct-2021 | Merger/Acquisition | 00000 | Drug Discovery | 000000000 |
Takeda Pharmaceutical Company Subsidiaries (9)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Takeda Ventures | Corporate Venture Capital | San Diego, CA | 2001 |
| 0000000 | Biotechnology | Leuven, Belgium | 0000 |
| 000000 00000000 | Drug Discovery | Cambridge, MA | 0000 |
| 000000 (0000000) | Distributors/Wholesale | Konstanz, Germany | 0000 |
| 00000 000000000000 | Biotechnology | Tokyo, Japan | 0000 |
Takeda Pharmaceutical Company Exits (10)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 00000000000 | 07-Dec-2017 | 000000000 00000000 | 00000 | Completed |
|
| 00000 | 05-Apr-2017 | 00000 00000 00 | 0000 | Completed |
|
| 000 000000 0000000 | 15-Feb-2017 | 00000 0000000 | Completed |
|
|
| 0000000 0000000000 | 14-Jun-2016 | 00000 00000 00 | 000.00 | Completed |
|
| Seagen | 17-Jan-2014 | PIPE | 000 | Completed |